Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
Rivus Capital
MunichSeed–Late Stage$5M – $20M
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
5 people
Cathay Health
San FranciscoSeed–Late Stage
1 person
Amethis
ParisGrowth–Late Stage
DSK Capital
Late Stage
Miura Partners SGEIC,
BarcelonaGrowth–Late Stage
Mother Ventures
New YorkSeed–Late Stage
2 people
Schouten Investments
AmsterdamSeries B–Late Stage
2 people
Meyer Ventures
New York CitySeed–Late Stage
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Gilmartin Capital LLC
LarkspurSeries A–Late Stage
2 people
Mayo Clinic Ventures
RochesterSeed–Late Stage
2 people
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
NDN2 vision fund
Hong KongPre-Seed–Late Stage
2 people
Yuuwa Capital
PerthPre-Seed–Late Stage
2 people
Analog Ventures
Mill ValleyPre-Seed–Late Stage
1 person
Nesta Ventures
LondonSeed–Late Stage
1 person
NJF Capital
LondonSeed–Late Stage
1 person
The Wells Investment
SeoulSeed–Late Stage
venture / science
San Francisco Bay AreaSeed–Late Stage
1 person
1521 Ventures
San FranciscoPre-Seed–Late Stage
1 person
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Avon River Ventures
Seed–Late Stage
1 person
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.










